Diversify Advisory Services LLC Has $394,000 Position in The Cigna Group (NYSE:CI)

Diversify Advisory Services LLC cut its position in The Cigna Group (NYSE:CIFree Report) by 15.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the health services provider’s stock after selling 220 shares during the quarter. Diversify Advisory Services LLC’s holdings in The Cigna Group were worth $394,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kovack Advisors Inc. acquired a new position in The Cigna Group during the 1st quarter worth approximately $214,000. Ashton Thomas Private Wealth LLC increased its position in The Cigna Group by 4.1% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 3,012 shares of the health services provider’s stock worth $1,094,000 after purchasing an additional 119 shares in the last quarter. Norden Group LLC increased its position in The Cigna Group by 22.3% during the 1st quarter. Norden Group LLC now owns 2,355 shares of the health services provider’s stock worth $855,000 after purchasing an additional 429 shares in the last quarter. J.W. Cole Advisors Inc. increased its position in The Cigna Group by 33.2% during the 1st quarter. J.W. Cole Advisors Inc. now owns 3,044 shares of the health services provider’s stock worth $1,106,000 after purchasing an additional 759 shares in the last quarter. Finally, Mission Wealth Management LP increased its position in The Cigna Group by 9.9% during the 1st quarter. Mission Wealth Management LP now owns 1,010 shares of the health services provider’s stock worth $367,000 after purchasing an additional 91 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CI has been the subject of a number of research analyst reports. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 2nd. Jefferies Financial Group upped their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. upped their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research report on Wednesday, August 21st. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Stephens restated an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research report on Friday, August 2nd. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group has a consensus rating of “Buy” and an average target price of $392.79.

View Our Latest Stock Report on CI

The Cigna Group Trading Up 0.6 %

NYSE:CI opened at $314.91 on Friday. The firm’s fifty day moving average is $346.52 and its 200-day moving average is $341.77. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.83. The firm has a market cap of $89.46 billion, a P/E ratio of 25.85, a P/E/G ratio of 1.05 and a beta of 0.50.

The Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.42 by $0.30. The business had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The Cigna Group’s revenue was up 24.6% on a year-over-year basis. During the same period in the prior year, the firm earned $6.13 earnings per share. Equities analysts expect that The Cigna Group will post 28.48 earnings per share for the current year.

The Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is presently 45.98%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.